HomeNews
Amyloidosis News provided by GoogleAlnylam Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript - Seeking Alpha
Seeking Alpha, NY - Nov 18, 2008So the treatment of the type of amyloidosis called TTR amyloidosis. TTR amyloidosis is a hereditary systemic disease caused by mutation in the TTR gene. ... |
Alnylam Pharmaceuticals Reports Third Quarter 2008 Financial Results - WELT ONLINE
ProteoTech to Present at Rodman & Renshaw's 10th Annual Healthcare ... - MarketWatch
MarketWatch - Nov 10, 2008Lastly, ProteoTech is developing a novel small molecule compound for the treatment of amyloidosis associated with type 2 diabetes. For further information ... |
Regulus Therapeutics and Collaborators Discover Role of a microRNA ... - Business Wire (press release)
Cedars-Sinai Researchers Present New Findings at Neuroscience Meetings - Newswise (press release)
Newswise (press release) - 8 hours ago18, 10 to 11 am, poster presentation: "Overexpression of S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease ... |
Leonard E. Hoyt - Superior Telegram
Superior Telegram, MN - 20 hours agoLen passed away at the Fairmont Medical Center in Fairmont of a rare disease, primary systemic amyloidosis (AL). The disease overtook his body but not his ... |
LIC asked to pay Rs 1 lakh claim to widow - Chandigarh Newsline
Chandigarh Newsline, India - 2 hours agoIn its reply, the LIC said Rani's husband was a chronic patient of pulmonary tuberculosis, bronchiectasis, renal amyloidosis and rapidly progressive renal ... |
Teen queen to fight for cure - South Morang, Mill Park, Bundoora Star
South Morang, Mill Park, Bundoora Star, Australia - Nov 10, 2008"I'm actually running my own campaign to raise $5000 by the end of the year for research into amyloidosis," she said. Ms Carew visits Rotary and Lions clubs ... |
Health & Fitness Calendar - Frederick News Post (subscription)
Frederick News Post (subscription), MD - Nov 17, 2008Amyloidosis support group meets Nov. 19, 1 pm, Bob Evans Restaurant, 1721 Dual Highway, Hagerstown, for lunch and fellowship. 301-797-7415. ... |
BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and ... - FOXBusiness
FOXBusiness - Nov 10, 2008... than 0.01 for the previous Phase II/III trial, should be sufficient to gain approval of eprodisate (KIACTA(TM)) for the treatment of AA Amyloidosis,. ... |
searching on Amyloidosis - Google News
|
|